CHMP1A Antikörper (AA 1-196)

Produktnummer ABIN7147514

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch CHMP1A in WB, ELISA, IHC und IF. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für CHMP1A Antikörper (AA 1-196) (ABIN7147514)

Target: CHMP1A (Charged Multivesicular Body Protein 1A (CHMP1A))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CHMP1A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Produktdetails anti-CHMP1A Antikörper

Bindungsspezifität: AA 1-196

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Charged multivesicular body protein 1a protein (1-196AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu CHMP1A

Target: CHMP1A (Charged Multivesicular Body Protein 1A (CHMP1A))

Andere Bezeichnung: CHMP1A

Hintergrund:

Background: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in cytokinesis. Involved in recruiting VPS4A and/or VPS4B to the midbody of dividing cells. May also be involved in chromosome condensation. Targets the Polycomb group (PcG) protein BMI1/PCGF4 to regions of condensed chromatin. May play a role in stable cell cycle progression and in PcG gene silencing.

Aliases: Charged multivesicular body protein 1a antibody, CHM1A_HUMAN antibody, CHMP1a antibody, Chromatin modifying protein 1a antibody, Chromatin-modifying protein 1a antibody, hVps46 1 antibody, hVps46-1 antibody, KIAA0047 antibody, Metalloprotease 1 antibody, PCOLN3 antibody, Procollagen (type III) N endopeptidase antibody, PRSM1 antibody, Vacuolar protein sorting 46 1 antibody, Vacuolar protein sorting-associated protein 46-1 antibody, Vps46 1 antibody, Vps46-1 antibody

UniProt: Q9HD42